Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
PaperCitations, authors & open-access status
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 511 citations, 2023 year and green oa status.
511
Citations
2023
Year
green
OA Status